Respiratory Failure

When assessing intubation/death at 7 days in hospitalized adults with acute respiratory failure, high-flow nasal oxygen was generally noninferior to noninvasive ventilation, according to results published in JAMA.

BOSTON — During COVID-19 hospitalization, patients faced lower odds for mortality and respiratory failure with vs. without documented cannabis use, according to data presented at the CHEST Annual Meeting.

BOSTON — When capturing ROX index in acute hypoxic respiratory failure, time from the start of high-flow nasal cannula therapy impacted the index’s sensitivity and specificity, according to data presented at the CHEST Annual Meeting.

BOSTON — Older adults hospitalized for an acute COPD exacerbation with vs. without metabolically healthy obesity were more likely to experience respiratory and cardiac complications, according to data presented at the CHEST Annual Meeting.

Among patients with COVID-19 and acute respiratory failure, survival at 1 year was more likely if they received nintedanib or pirfenidone antifibrotics, according to results published in BMC Pulmonary Medicine.

Editor’s note: This is the first in a series of five stories from ASCO Voices, a session during the 2024 ASCO Annual Meeting focused on the human side of oncology.

Use of the 2015 Pediatric Acute Lung Injury Consensus Conference, or PALICC, criteria for diagnosing pediatric acute respiratory distress syndrome mostly resulted in agreement between two physicians, according to results published in CHEST.

Among new nurses, receipt of virtual reality-based training vs. usual orientation led to more correct identification of respiratory distress in pediatric patients, according to results published in American Journal of Critical Care.

Adults on mechanical ventilation for COVID-19 pneumonia showed improvements in oxygenation with high-dose inhaled nitric oxide, according to results published in American Journal of Respiratory and Critical Care Medicine.

With high expectations for independence in daily activities, 71% of survivors of acute respiratory failure achieved what they hoped for 6 months after discharge, according to results published in Annals of the American Thoracic Society.